{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T20:16:53Z","timestamp":1771532213530,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s40261-025-01460-9","type":"journal-article","created":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T15:19:15Z","timestamp":1751123955000},"page":"575-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pregabalin and Methadone Plasma Levels in Patients Receiving Methadone Maintenance Treatment: An Observational Study"],"prefix":"10.1007","volume":"45","author":[{"given":"Anat","family":"Sason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Adelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaul","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7091-7987","authenticated-orcid":false,"given":"Einat","family":"Peles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"issue":"6","key":"1460_CR1","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/dta.2347","volume":"10","author":"F Ianni","year":"2018","unstructured":"Ianni F, Aroni K, Gili A, Sardella R, Bacci M, Lancia M, et al. GC-MS\/MS detects potential pregabalin abuse in susceptible subjects\u2019 hair. Drug Test Anal. 2018;10(6):968\u201376.","journal-title":"Drug Test Anal"},{"key":"1460_CR2","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharm acokinet. 2010;49:661\u20139.","journal-title":"Clin. Pharm acokinet."},{"key":"1460_CR3","unstructured":"Drug Enforcement Administration. Department of Justice. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule. Fed Regist. 2005;70:43633\u20135."},{"key":"1460_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059981","volume":"8","author":"MC Garassino","year":"2013","unstructured":"Garassino MC, Piva S, La Verde N, Spagnoletti I, Iorno V, Carbone C, et al. Randomised phase II trial (NCT00637975) evaluating activity and toxicity of two different escalating strategies for pregabalin and oxycodone combination therapy for neuropathic pain in cancer patients. PLoS ONE. 2013;8: e59981.","journal-title":"PLoS ONE"},{"key":"1460_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.893590","volume":"13","author":"C Bertin","year":"2022","unstructured":"Bertin C, Bezin J, Chenaf C, Delorme J, Kerckhove N, Pariente A, et al. Oral morphine as an alternative substitution treatment for opioid use disorder, a rare but non-risk-free use. Front Psychiatry. 2022;13: 893590.","journal-title":"Front Psychiatry."},{"key":"1460_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","volume":"174","author":"T Abrahamsson","year":"2017","unstructured":"Abrahamsson T, Berge J, \u00d6jehagen A, H\u00e5kansson A. Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study. Drug Alcohol Depend. 2017;174:58\u201364.","journal-title":"Drug Alcohol Depend"},{"key":"1460_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2014.04.028","volume":"241","author":"M H\u00e4kkinen","year":"2014","unstructured":"H\u00e4kkinen M, Vuori E, Kalso E, Gergov M, Ojanpera I. Profiles of pregabalin and gabapentin abuse by postmortem toxicology. Forensic Sci Int. 2014;241:1\u20136.","journal-title":"Forensic Sci Int"},{"key":"1460_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pbb.2011.10.023","volume":"100","author":"JP Zacny","year":"2012","unstructured":"Zacny JP, Paice JA, Coalson DW. Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers. Pharmacol Biochem Behav. 2012;100:560\u20135.","journal-title":"Pharmacol Biochem Behav"},{"key":"1460_CR9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","volume":"69","author":"M Grosshans","year":"2013","unstructured":"Grosshans M, Lemenager T, Vollmert C, K\u00e4mmerer N, Screiner R, Mutschler J, et al. Pregabalin abuse among opiate addicted patients. Eur J Clin Pharmacol. 2013;69:2021\u20135.","journal-title":"Eur J Clin Pharmacol"},{"key":"1460_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2018.04.025","volume":"189","author":"A Sason","year":"2018","unstructured":"Sason A, Adelson M, Schreiber S, Peles E. Pregabalin misuse in methadone maintenance treatment patients in Israel: prevalence and risk factors. Drug Alcohol Depend. 2018;189:8\u201311.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"1460_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000355268","volume":"20","author":"CR Baird","year":"2014","unstructured":"Baird CR, Fox P, Colvin LA. Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers. Eur Addict Res. 2014;20(3):115\u20138. https:\/\/doi.org\/10.1159\/000355268.","journal-title":"Eur Addict Res"},{"key":"1460_CR12","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3389\/fpsyt.2019.01022","volume":"10","author":"M Lancia","year":"2020","unstructured":"Lancia M, Gambelunghe A, Gili A, Bacci M, Aroni K, Gambelunghe C. Pregabalin abuse in combination with other drugs: monitoring among methadone patients. Front Psychiatry. 2020;10:1022.","journal-title":"Front Psychiatry."},{"key":"1460_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/bcp.12576","volume":"79","author":"S Mouly","year":"2015","unstructured":"Mouly S, Bloch V, Peoc\u2019h K, et al. Methadone dose in heroin dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity. Br J Clin Pharmacol. 2015;79:967\u201377.","journal-title":"Br J Clin Pharmacol"},{"key":"1460_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2217\/pgs.13.58","volume":"14","author":"O Levran","year":"2013","unstructured":"Levran O, Peles E, Randesi M, et al. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics. 2013;14:755\u201368.","journal-title":"Pharmacogenomics"},{"issue":"7","key":"1460_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2217\/pgs.13.58","volume":"14","author":"O Levran","year":"2013","unstructured":"Levran O, Peles E, Randesi M, Shu X, Ott J, Shen PH, Adelson M, Kreek MJ. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics. 2013;14(7):755\u201368. https:\/\/doi.org\/10.2217\/pgs.13.58.","journal-title":"Pharmacogenomics"},{"issue":"6","key":"1460_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/ADM.0b013e3182a8a4f2","volume":"7","author":"E Peles","year":"2013","unstructured":"Peles E, Linzy S, Kreek MJ, Adelson M. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk. J Addict Med. 2013;7(6):428\u201334.","journal-title":"J Addict Med"},{"key":"1460_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/10826084.2017.1298619","volume":"53","author":"M Adelson","year":"2018","unstructured":"Adelson M, Linzy S, Peles E. Characteristics and outcome of male and female methadone maintenance patients: MMT in Tel Aviv and Las Vegas. Subst Use Misuse. 2018;53:230\u20138.","journal-title":"Subst Use Misuse"},{"key":"1460_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","volume":"185","author":"E Peles","year":"2018","unstructured":"Peles E, Schreiber S, Sason A, Adelson M. Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center. Drug Alcohol Depend. 2018;185:112\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1460_CR19","first-page":"30","volume":"73","author":"RL Hawks","year":"1986","unstructured":"Hawks RL. Analytical methodology. NIDA. Res Monogr. 1986;73:30\u201342.","journal-title":"Res Monogr"},{"issue":"23","key":"1460_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"1960","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;1960(23):56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1460_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/03610928008827941","volume":"A10","author":"DW Hosmer","year":"1980","unstructured":"Hosmer DW, Lemeshow S. A goodness-of-fit test for the multiple logistic regression model. Commun Stat. 1980;A10:1043\u201369.","journal-title":"Commun Stat"},{"issue":"14","key":"1460_CR22","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2146\/ajhp060371","volume":"64","author":"ML Blommel","year":"2007","unstructured":"Blommel ML, Blommel AL. Pregabalin: an antiepileptic agent useful for neuropathic pain. Am J Health Syst Pharm. 2007;64(14):1475\u201382.","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"1460_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/02791072.2020.1861392","volume":"53","author":"E Peles","year":"2021","unstructured":"Peles E, Sason A, Schreiber S, Adelson M. Pregabalin misuse: motives, pattern, and knowledge about its risks among patients in methadone maintenance treatment. J Psychoact Drugs. 2021;53(3):238\u201346.","journal-title":"J Psychoact Drugs"},{"key":"1460_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hup.2512","volume":"31","author":"P Heikman","year":"2016","unstructured":"Heikman P, Sundstr\u00f6m M, Pelander A, Ojanper\u00e4 I. New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening. Hum Psychopharmacol. 2016;31:44\u201352.","journal-title":"Hum Psychopharmacol"},{"key":"1460_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40263-014-0192-0","volume":"28","author":"JE Frampton","year":"2014","unstructured":"Frampton JE. Pregabalin: a review of its use in adults with generalized anxiety disorder. CNS Drugs. 2014;28:835\u201354.","journal-title":"CNS Drugs"},{"key":"1460_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2165\/00003495-199244020-00001","volume":"44","author":"JW Tiller","year":"1992","unstructured":"Tiller JW, Schweitzer I. Benzodiazepines. Depressants or antidepressants? Drugs. 1992;44:165\u20139.","journal-title":"Drugs"},{"key":"1460_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/00002018-199410030-00003","volume":"10","author":"SB Patten","year":"1994","unstructured":"Patten SB, Love EJ. Drug-induced depression. Incidence, avoidance and management. Drug Saf. 1994;10:203\u201319.","journal-title":"Drug Saf"},{"issue":"10","key":"1460_CR28","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/add.16261","volume":"118","author":"T Soeiro","year":"2023","unstructured":"Soeiro T, Pradel V, Lapeyre-Mestre M, Micallef J. Systematic assessment of non-medical use of prescription drugs using doctor-shopping indicators: a nation-wide, repeated cross-sectional study. Addiction. 2023;118(10):1984\u201393.","journal-title":"Addiction"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01460-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01460-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:59:25Z","timestamp":1757203165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01460-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1460"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01460-9","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"17 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was funded by the Adelson Family Foundation. The study\u2019s design, data collection, analysis, interpretation, and manuscript writing were independent of the funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study analyses were approved by the Helsinki Committee (IRB) 07-111 of the Tel Aviv Sourasky Medical Center. The study was performed under the standards of ethics outlined in the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided signed informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Data can be provided on reasonable request to the corresponding author.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data"}},{"value":"Einat Peles did the statistical analyses and wrote the manuscript together with Shaul Schreiber. Miriam Adelson participated in writing. Anat Sason collected the data for the analyses. All authors read and approved the final version, and agree to be accountable for the work","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}